MARKET

PLX

PLX

Protalix Biother
AMEX
2.035
+0.025
+1.24%
Opening 13:13 05/21 EDT
OPEN
1.970
PREV CLOSE
2.010
HIGH
2.065
LOW
1.970
VOLUME
369.87K
TURNOVER
--
52 WEEK HIGH
3.190
52 WEEK LOW
1.320
MARKET CAP
163.96M
P/E (TTM)
-24.1974
1D
5D
1M
3M
1Y
5Y
1D
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
TipRanks · 5h ago
Weekly Report: what happened at PLX last week (0511-0515)?
Weekly Report · 3d ago
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
TipRanks · 05/14 00:15
Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone
Seeking Alpha · 05/13 15:52
CORRECTION: Protalix BioTherapeutics Q1 EPS $0.22 Beats $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate
Benzinga · 05/13 13:37
Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call
Benzinga · 05/13 12:19
Earnings Scheduled For May 13, 2026
Benzinga · 05/13 11:11
Protalix BioTherapeutics Q1 EPS $0.05 Misses $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate
Benzinga · 05/13 11:02
More
About PLX
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of uncontrolled gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase) - a chemically modified enzyme to treat uncontrolled gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate. Its product includes Elelyso and Elfabrio. Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease.

Webull offers Protalix Biotherapeutics Inc stock information, including AMEX: PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.